Cancer-Help.org provides news and information on cancer,  
gathering articles on hundreds of cancer-related topics  
from more than 1,500 sources across the web.  
Here and Now: Inspiring Stories of Cancer Survivors --
by Elena Dorfman, Heidi Schultz Adams
Kathy's Hats: A Story of Hope Kathy's Hats: A Story of Hope
by Trudy Krisher
My Mommy's Cancer
by Cindy Klein Cohen
Beating Cancer With Nutrition
by Patrick Quillin
A Cancer Battle Plan: Six Strategies for Beating Cancer, from a Recovered "Hopeless Case"
by Anne E. Frahm, David J. Frahm
How to Fight Cancer & Win
by William L. Fischer
What to Eat if You Have Cancer
by Daniella Chace
The Cure for All Cancers: Including over 100 Case Histories of Persons Cured
by Hulda Regehr Clark
Just Get Me Through This: The Practical Guide to Breast Cancer
by Deborah A. Cohen

    ABX-EGF

    A type of monoclonal antibody being studied in the diagnosis and treatment of cancer. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. (National Cancer Institute)



    Archives: The following articles may no longer be available on the web. If you want to inquire on a particular article, please contact the source publication (listed in parentheses).



    <**results**>
    Zacks.com Expert Watch Highlights the Following Stocks: Imclone ... Jul 1, 2004
    ...their EGFR treatment. The company's report on ABX-EGF places it on par with Erbitux, according the Wongs. Specifically, patients ... Business Wire (press release), CA -

    New cancer drugs - - off to strong start on long journey Jun 14, 2004
    Positive data were also presented on two others: ImClone's Erbitux and ABX-EGF from Abgenix Inc. of Fremont and Amgen Inc. of Thousand Oaks (Ventura County). ... San Francisco Chronicle, CA -

    Interim Phase 2 Data Show Panitumumab Has Single-Agent Antitumor ... Jun 6, 2004
    ...a leading antibody development company, today announced interim data from an ongoing Phase 2 study demonstrating that panitumumab (formerly ABX-EGF), a fully ... Business Wire (press release), CA -


    Resources from the National Cancer Institute on ABX-EGF:

    Cancer.gov  Phase I Study of Monoclonal Antibody ABX-EGF in Patients With Renal, Prostate, Pancreatic, Non-Small Cell Lung, Colorectal, Esophageal, or Gastroesophageal ...
    Cancer.gov  A clinical trial evaluating ABX-EGF (a monoclonal antibody) given to patients with prostate cancer with or without tumor in other parts of the body. ...
    Cancer.gov  Continuation Study of Monoclonal Antibody ABX-EGF (MOAB ABX-EGF) in Patients With Metastatic Renal Cell Carcinoma That Stabilized or Responded to Prior MOAB ABX ...
    Cancer.gov  Phase II Study of Monoclonal Antibody ABX-EGF, Irinotecan, Leucovorin Calcium, and Fluorouracil in Patients With Metastatic Colorectal Cancer. ...
    Cancer.gov  No CNS involvement. Prior/Concurrent Therapy: Biologic therapy. No prior cetuximab or monoclonal antibody ABX-EGF. Chemotherapy. At ...
    ABX-EGF :  ABX-EGF : A type of monoclonal antibody being studied in the diagnosis and treatment of cancer. Monoclonal antibodies are laboratory ...


Google
  Web cancer-help.org

Home | Cancers | Treatments | Regional! | Vitamins | Vaccines | Health | Hospitals | About
Lottery News Futures Trading News
Copyright Cancer-Help.org 2003-2004.
All Rights Reserved.